The Top AI News Stories Today

OpenAI has paused new sign-ups for its Pro subscription tier to manage infrastructure strain caused by demand for Astra, its latest AI model. The company said Pro subscriptions place the most load on its systems and suspended onboarding while adding capacity to handle the surge. Source Anthropic released a report Thursday detailing persistent distillation attacks

Listen Labs, an AI research startup, walked away from a signed Series C term sheet from Menlo Ventures, according to sources familiar with the matter. The company scrubbed the $1.5bn funding round to pursue talks with Salesforce instead. Source Paul Christiano, an influential AI researcher focused on alignment, has joined the OpenAI Foundation as a

Mistral, a French AI lab, has raised €3 billion at a €21 billion valuation in a Series D round led by Samsung, Scaleup Europe, and PSG Equity. The funding underscores growing investor appetite for AI companies positioned as alternatives to American incumbents, a trend described as the rise of sovereign AI. Source OpenAI announced that

Artificial intelligence was used to help develop rentosertib, a drug candidate for a rare lung condition, and early data suggests it may also slow biological hallmarks of aging. The drug's maker says the compound shows promise in addressing age-related decline, marking what could be the first practical demonstration of AI-assisted drug discovery yielding a candidate

The Seattle Times and Newsday have sued OpenAI and Microsoft for copyright infringement, alleging the companies used their journalism as training data without permission. The news outlets claim OpenAI's models often reproduce passages from their reporting in response to user queries. The lawsuits join a growing roster of copyright cases filed against the AI company.